comparemela.com

Latest Breaking News On - Alimera sciences inc - Page 4 : comparemela.com

Alimera Sciences (NASDAQ:ALIM) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research note released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Alimera Sciences Price Performance Shares of NASDAQ ALIM opened at $3.90 on Friday. The business has a fifty day moving average price of $3.56 and […]

United-states
Alimera-sciences-inc
Alimera-sciences-price-performance
Institutional-investors-weigh-in-on-alimera-sciences
Susquehanna-international-group
News-ratings-for-alimera-sciences-daily
Alimera-sciences
Capital-management
Worth-venture-partners
Stonepine-capital-management
Free-report

Alimera Sciences (NASDAQ:ALIM) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Alimera Sciences Price Performance Shares of NASDAQ:ALIM opened at $4.08 on Friday. Alimera Sciences has a 52 week low of $1.30 and a 52 week […]

United-states
Capital-management
Vanguard-group-inc
Nasdaq
Tower-research-capital
Alimera-sciences-inc
News-ratings-for-alimera-sciences-daily
Alimera-sciences-price-performance
Stonepine-capital-management
Alimera-sciences
Worth-venture-partners

Ocular Drug Delivery Technology Market Production, Business Analysis, Rising Trends and CAGR | Alimera Sciences Inc, Valeant Pharmaceuticals International Inc

Ocular Drug Delivery Technology Market Production, Business Analysis, Rising Trends and CAGR | Alimera Sciences Inc, Valeant Pharmaceuticals International Inc
eturbonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eturbonews.com Daily Mail and Mail on Sunday newspapers.

Canada
Brazil
Mexico
Italy
India
Egypt
Philippines
New-york
United-states
Pune
Maharashtra
Thailand

StockNews.com Initiates Coverage on Alimera Sciences (NASDAQ:ALIM)

StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. Alimera Sciences Price Performance Shares of NASDAQ:ALIM opened at $3.81 on Friday. The company’s fifty day moving average price is $3.44 and its 200 day moving […]

United-states
Tower-research-capital
Vanguard-group-inc
News-ratings-for-alimera-sciences-daily
Alimera-sciences-price-performance
Stonepine-capital-management
Nasdaq
Alimera-sciences-inc
Capital-management
Alimera-sciences
Worth-venture-partners

Analysts' New Coverage for December 23rd (AGLE, AINC, ALIM, APDN, BKCC, BKSC, BLIN, BYFC, CASI, CBFV)

Analysts’ new coverage for Saturday, December 23rd: StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). StockNews.com issued a sell rating on the stock. StockNews.com initiated coverage on shares of Ashford (NYSEAMERICAN:AINC). They issued a buy rating on the stock. StockNews.com began coverage on shares of Alimera Sciences (NASDAQ:ALIM). StockNews.com issued a hold rating on […]

United-states
South-carolina
Aeglea-biotherapeutics-inc
News-ratings-for-aeglea-biotherapeutics-inc-daily
Codorus-valley-bancorp
Nasdaq
Cb-financial-services
Creative-media-community-trust-co
Pieris-pharmaceuticals
Alimera-sciences
Computer-task-group

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.